Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines

作者: Thai Thanh Hoang Thi , Estelle JA Suys , Jung Seok Lee , Dai Hai Nguyen , Ki Dong Park

DOI: 10.3390/VACCINES9040359

关键词:

摘要: … have made it to the market consisting of diverse … nanoparticles and their structure/property relationship. Next, we survey lipid nanoparticles that have been successfully used for cancer …

参考文章(127)
Suvasini Ramaswamy, Nina Tonnu, Kiyoshi Tachikawa, Pattraranee Limphong, Jerel B. Vega, Priya P. Karmali, Pad Chivukula, Inder M. Verma, Systemic delivery of factor IX messenger RNA for protein replacement therapy Proceedings of the National Academy of Sciences of the United States of America. ,vol. 114, pp. 201619653- ,(2017) , 10.1073/PNAS.1619653114
J. Cehelsky, A. White, I. Toudjarska, D. Bumcrot, R. Meyers, G. Hinkle, N. Svrzikapa, D. W. Sah, A. Vaishnaw, J. Gollob, H. A. Burris, A. Cervantes, M. Alsina, J. Tabernero, J. R. Infante, P. LoRusso, G. Shapiro, L. G. Paz-Ares, R. Falzone, J. Hill, Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement. Journal of Clinical Oncology. ,vol. 29, pp. 3025- 3025 ,(2011) , 10.1200/JCO.2011.29.15_SUPPL.3025
Michael J. Wagner, Rahul Mitra, Mark J. McArthur, Wallace Baze, Kirstin Barnhart, Sherry Y. Wu, Cristian Rodriguez-Aguayo, Xinna Zhang, Robert L. Coleman, Gabriel Lopez-Berestein, Anil K. Sood, Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA). Molecular Cancer Therapeutics. ,vol. 16, pp. 1114- 1123 ,(2017) , 10.1158/1535-7163.MCT-16-0541
Anastasia Khvorova, Jonathan K Watts, The chemical evolution of oligonucleotide therapies of clinical utility. Nature Biotechnology. ,vol. 35, pp. 238- 248 ,(2017) , 10.1038/NBT.3765
Upendra Bulbake, Sindhu Doppalapudi, Nagavendra Kommineni, Wahid Khan, Liposomal formulations in clinical use: An updated review Pharmaceutics. ,vol. 9, pp. 12- ,(2017) , 10.3390/PHARMACEUTICS9020012
Hedi Hunt, Lorena Simón-Gracia, Allan Tobi, Venkata Ramana Kotamraju, Shweta Sharma, Mait Nigul, Kazuki N. Sugahara, Erkki Ruoslahti, Tambet Teesalu, Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles Journal of Controlled Release. ,vol. 260, pp. 142- 153 ,(2017) , 10.1016/J.JCONREL.2017.06.005
Srinivasa Reddy Bonam, Charalambos D. Partidos, Sampath Kumar M. Halmuthur, Sylviane Muller, An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy Trends in Pharmacological Sciences. ,vol. 38, pp. 771- 793 ,(2017) , 10.1016/J.TIPS.2017.06.002
Christos Tapeinos, Matteo Battaglini, Gianni Ciofani, Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. Journal of Controlled Release. ,vol. 264, pp. 306- 332 ,(2017) , 10.1016/J.JCONREL.2017.08.033
Jérôme Widmer, Cédric Thauvin, Inès Mottas, Van Nga Nguyen, Florence Delie, Eric Allémann, Carole Bourquin, Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation. International Journal of Pharmaceutics. ,vol. 535, pp. 444- 451 ,(2018) , 10.1016/J.IJPHARM.2017.11.031